Review of the recommendations of the American College of Rheumatology and the American Association of Hip and Knee Surgeons on hip or knee arthroplasty for patient with osteoarthritis
https://doi.org/10.47360/1995-4484-2026-126-132
Abstract
The review is devoted to the analytical analysis of the recommendations of the American College of Rheumatology and the American Association of Hip and Knee Surgeons on the optimal time for elective total arthroplasty of the knee or hip joints in patients with moderate to severe osteoarthritis (OA), moderate to severe pain and loss of function, Kellgren – Lawrence radiological stages III–IV, who have received ≥1 course of appropriate conservative therapy that has been ineffective. The discussion focuses on whether to delay surgical treatment or continue with physiotherapy, intra-articular glucocorticoid injections, or viscoelastic synovial fluid implants, whether to wait for improvement with the use of mobility aids or orthoses, and whether to postpone surgery until significant weight loss or glucose control is achieved in severe OA patients with concomitant diabetes mellitus who require knee or hip arthroplasty.
About the Authors
V. N. Amirjanova
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
Competing Interests:
Russian Federation
Vera N. Amirjanova
115522, Moscow, Kashirskoye Highway, 34A
Competing Interests:
none
E. L. Nasonov
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
Competing Interests:
Russian Federation
Evgeny L. Nasonov
115522, Moscow, Kashirskoye Highway, 34A
Competing Interests:
none
A. M. Lila
V.A. Nasonova Research Institute of Rheumatology; Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of the Russian Federation
Russian Federation
Competing Interests:
Russian Federation
Aleksander M. Lila
115522, Moscow, Kashirskoye Highway, 34A; 125993, Moscow, Barrikadnaya str., 2/1, building 1
Competing Interests:
none
References
1. All-Russian Public Organization “Association of Traumatologists and Orthopedists of Russia” (ATOR), All-Russian Public Organization “Association of Rheumatologists of Russia” (ARR), All-Russian Public Organization “Association of Rehabilitation Specialists of Russia.” Gonarthrosis: Clinical guidelines. Moscow;2024 (In Russ.). URL: https://cr.minzdrav.gov.ru/preview-cr/868_1 (Accessed: 1st January 2025).
2. All-Russian Public Organization «Association of Traumatologists and Orthopedists of Russia» (ATOR), All-Russian Public Organization «Association of Rheumatologists of Russia» (ARR), All-Russian Public Organization «Association of Rehabilitation Specialists of Russia.» Coxarthrosis: Clinical guidelines. Moscow;2024 (In Russ.). URL: https://cr.minzdrav.gov.ru/preview-cr/870_1 (Accessed: 1st January 2025).
3. Kellgren JH, Jeffrey M, Ball J. Atlas of standard radiographs. Oxford:Blackwell Scientific;1963:493-496.
4. Torshin IYu, Lila AM, Naumov AV, Kochish AYu, Alekseeva LI, Taskina EA, et al. Meta-analysis of clinical trials of osteoarthritis treatment effectiveness with Chondroguard. Farmakoekonomika. Modern Pharmacoeconomics and Pharmacoepidemiology. 2020;13(4):388-399 (In Russ.). doi: 10.17749/2070-4909/farmakoekonomika.2020.066
5. Mazieres B, Combe B, Phan VA, Tondut J, Grynfeltt M. Chondroitin sulfate in osteoarthritis of the knee: A prospective, double blind, placebo controlled multicenter clinical study. J Rheumatol. 2001;28(1):173-181. doi: 10.12691/bse-3-1-5
6. Mehta K, Gala J, Bhasale S, Naik S, Modak M, Thakur H, et al. Comparison of glucosamine sulfate and a polyherbal supplement for the relief of osteoarthritis of the knee: A randomized controlled trial [ISRCTN25438351]. BMC Complement Altern Med. 2007;7:34. doi: 10.1186/1472-6882-7-34
7. Pavelka K, Coste P, Geher P, Krejci G. Efficacy and safety of piascledine 300 versus chondroitin sulfate in a 6 months treatment plus 2 months observation in patients with osteoarthritis of the knee. Clin Rheumatol. 2010;29(6):659-670. doi: 10.1007/s10067-010-1384-8
8. Alekseeva LI, Sharapova EP, Taskina EA, Chichasova NV, Imametdinova GR, Shostak NA, et al. A multicenter, blind, randomized, placebo-controlled study of the symptomand structure-modifying effect of alflutop in patients with knee osteoarthritis. Report 2: The assessment of the structuremodifying effect of the drug. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2014;52(2):174-177 (In Russ.). doi: 10.14412/1995-4484-2014-174-177
9. Shavlovskaya OA, Gromova ОА, Torshin IYu, Romanov ID. From misconceptions to reasonable osteoarthritis patients therapy. Farmakoekonomika. Modern Pharmacoeconomics and Pharmacoepidemiology. 2023;16(2):317-330 (In Russ.). doi: 10.17749/2070-4909/farmakoekonomika.2023.183
10. Lila AM, Tkacheva ON, Naumov AV, Alekseeva LI, Kochish AYu, Kotovskaya YuV, et al. Place and role of the parenteral form of chondroitin sulfate in the treatment of osteoarthritis: Multidisciplinary consensus. RMJ. 2021;6:68-74 (In Russ.).
11. Altman RD, Akermark C, Beaulieu AD, Schnitzer T. Efficacy and safety of a single intraarticular injection of non-animal stabilized hyaluronic acid (NASHA) in patients with osteoarthritis of the knee. Osteoarthritis Cartilage. 2004;12(8):642-649. doi: 10.1016/j.joca.2004.04.010
12. Day R, Brooks P, Conaghan PG, Petersen M. A double blind, randomized, multicenter, parallel group study of the effectiveness and tolerance of intraarticular hyaluronan in osteoarthritis of the knee. J Rheumatol. 2004;31(4):775-782.
13. Petukhov AI, Kornilov NN, Kulyaba TA. Injectable hyaluronic acid drugs for the treatment of knee osteoarthritis in the context of evidence-based medicine. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2018;56(2):239-248 (In Russ.). doi: 10.14412/1995-4484-2018-239-248
14. Bennell KL, Hunter DJ, Paterson KL. Platelet-rich plasma for the management of hip and knee osteoarthritis. Curr Rheumatol Rep. 2017;19(5):24. doi: 10.1007/s11926-017-0652-x
15. Pak J, Lee JH, Kartolo WA, Lee SH. Cartilage regeneration in human with adipose tissuederived stem cells: Current status in clinical implications. BioMed Res Int. 2016:2016:4702674. doi: 10.1155/2016/4702674
16. Billesberger LM, Fisher KM, Qadri YJ, Boortz-Marx RL. Procedural treatments for knee osteoarthritis: A review of current injectable therapies. Pain Res Manag. 2020;2020:3873098. doi: 10.1155/2020/3873098
17. Novoselov KA, Kornilov NN, Kulyaba TA. Injuries and diseases of the knee joint. Kornilov NV. Traumatology and Orthopedics. St. Petersburg:Gippokrat;2006:213-438 (In Russ.).
18. Bruyère O, Honvo G, Veronese N, Arden NK, Branco J, Curtis EM, et al. An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Semin Arthritis Rheum. 2019;49(3):337-350. doi: 10.1016/j.semarthrit.2019.04.008
19. Alekseeva LI. Сlinical guidelines update on the treatment of patients with osteoarthritis in 2019. RMJ. 2019;4:2-6 (In Russ.).
20. Preobrazhensky PM, Fil AS, Kornilov NN, Panteleev AN, Guatsaev MS, Kazemirsky AV, et al. Current state of knee arthroplasty in Russia: Analysis of 36,350 сases from the register of the Vreden National Medical Research Center of Traumatology and Orthopedics. Traumatology and Orthopedics of Russia. 2023;29(3):73-85 (In Russ.). doi: 10.17816/2311-2905-9349
21. Bozhkova SA, Tikhilov RM, Andriyashkin VV, Akhtyamov IF, Belov MV, Dianov SV, et al. Prevention, diagnosis and treatment of thromboembolic complications in traumatology and orthopedics: Methodological guidelines. Traumatology and Orthopedics of Russia. 2022;28(3):136-166 (In Russ.). doi: 10.17816/2311-2905-1993
22. Hannon CP, Goodman SM, Austin MS, Yates A Jr, Guyatt G, Aggarwal VK, et al. 2023 American College of Rheumatology and American Association of Hip and Knee Surgeons clinical practice guideline for the optimal timing of elective hip or knee arthroplasty for patients with symptomatic moderate-to-severe osteoarthritis or advanced symptomatic osteonecrosis with secondary arthritis for whom nonoperative therapy is ineffective. Arthritis Care Res (Hoboken). 2023;75(11):2227-2238. doi: 10.1002/acr.25175
23. Kolasinski SL, Neogi T, Hochberg MC, Oatis C, Guyatt G, Block J, et al. 2019 American College of Rheumatology/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Rheumatol. 2020;72(2):220-233. doi: 10.1002/art.41142
24. Gränicher P, Mulder L, Lenssen T, Scherr J, Swanenburg J, de Bie R. Prehabilitation improves knee functioning before and within the first year after total knee arthroplasty: A systematic review with meta-analysis. J Orthop Sports Phys Ther. 2022;52(11):709-725. doi: 10.2519/jospt.2022.11160
25. Skou ST, Roos EM, Laursen MB, Rathleff MS, Arendt-Nielsen L, Rasmussen S, et al. Total knee replacement and non-surgical treatment of knee osteoarthritis: 2-year outcome from two parallel randomized controlled trials. Osteoarthritis Cartilage. 2018;26(9):11701180. doi: 10.1016/j.joca.2018.04.014
26. Karateev AE, Lila AM, Mazurov VI, Nasonov EL, Drapkina OM, Alekseeva LI, et al. Expert consensus 2024: Rational use of non-steroidal anti-inflammatory drugs. Modern Rheumatology Journal. 2025;19(S1):1-40 (In Russ.). doi: 10.14412/1996-7012-2025-1S-1-40
27. Alkjaer T, Larsen PK, Pedersen G, Nielsen LH, Simonsen EB. Biomechanical analysis of rollator walking. Biomed Eng Online. 2006;5:2. doi: 10.1186/1475-925X-5-2
28. Mahoney J, Euhardy R, Carnes M. A comparison of a twowheeled walker and a three-wheeled walker in a geriatric population. J Am Geriatr Soc. 1992;40:208-212. doi: 10.1111/j.1532-5415.1992.tb02069.x
29. Habib G, Chernin M, Sakas F, Artul S, Jabbour A, Jabaly- Habib H. The impact of intra-articular depot betamethasone injection on insulin resistance among diabetic patients with osteoarthritis of the knee: A case-control study. J Clin Rheumatol. 2018;24(4):193-196. doi: 10.1097/RHU.0000000000000614
30. Lai Q, Cai K, Lin T, Zhou C, Chen Z, Zhang Q. Prior intra-articular corticosteroid injection within 3 months may increase the risk of deep infection in subsequent joint arthroplasty: A meta-analysis. Clin Orthop Relat Res. 2022;480(5):971-979. doi: 10.1097/CORR.0000000000002055
31. Pereira TV, Jüni P, Saadat P, Xing D, Yao L, Bobos P, et al. Viscosupplementation for knee osteoarthritis: Systematic review and metaanalysis. BMJ. 2022;378:e069722. doi: 10.1136/bmj-2022-069722
32. Rutjes AW, Jüni P, da Costa BR, Trelle S, Nüesch E, Reichenbach S. Viscosupplementation for osteoarthritis of the knee: A systematic review and meta-analysis. Ann Intern Med. 2012;157(3):180-191. doi: 10.7326/0003-4819-157-3-201208070-00473
33. Wagner ER, Kamath AF, Fruth K, Harmsen WS, Berry DJ. Effect of body mass index on reoperation and complications after total knee arthroplasty. J Bone Joint Surg Am. 2016;98:2052-2060. doi: 10.2106/JBJS.16.00093
34. Wagner ER, Kamath AF, Fruth KM, Harmsen WS, Berry DJ. Effect of body mass index on complications and reoperations after total hip arthroplasty. J Bone Joint Surg Am. 2016;98:169-179. doi: 10.2106/JBJS.O.00430
35. Collins JE, Donnell-Fink LA, Yang HY, Usiskin IM, Lape EC, Wright J, et al. Effect of obesity on pain and functional recovery following total knee arthroplasty. J Bone Joint Surg Am. 2017;99(21):1812-1818. doi: 10.2106/JBJS.17.00022
36. Na A, Middleton A, Haas A, Graham JE, Ottenbacher KJ. Impact of diabetes on 90-day episodes of care after elective total joint arthroplasty among Medicare beneficiaries. J Bone Joint Surg Am. 2020;102:2157-2165.doi: 10.2106/JBJS.20.00203
37. Duchman KR, Gao Y, Pugely AJ, Martin CT, Noiseux NO, Callaghan JJ. The effect of smoking on short -term complications following total hip and knee arthroplasty. J Bone Joint Surg Am. 2015;97(13):1049-1058. doi: 10.2106/JBJS.N.01016
38. Tischler EH, Matsen Ko L, Chen AF, Maltenfort MG, Schroeder J, Austin MS. Smoking increases the rate of reoperation for infection within 90 days after primary total joint arthroplasty. J Bone Joint Surg Am. 2017;99(4):295-304. doi: 10.2106/jBJS.16.00311
39. Tibbo ME, Chalmers BP, Berry DJ, Pagnano MW, Lewallen DG, Abdel MP. Primary total knee arthroplasty in patients with neuropathic (charcot) arthropathy: Contemporary results. J Arthroplasty. 2018;33(9):2815-2820. doi: 10.1016/j.arth.2018.04.003
40. Riddle DL, Perera RA, Jiranek WA, Dumenci L. Using surgical appropriateness criteria to examine outcomes of total knee arthroplasty in a United States sample. Arthritis Care Res (Hoboken). 2015;67:349-357. doi: 10.1002/acr.22428
41. Ghomrawi HMK, Mushlin AI, Kang R, Banerjee S, Singh JA, Sharma L, et al. Examining timeliness of total knee replacement among patients with knee osteoarthritis in the U.S.: Results from the OAI and MOST longitudinal cohorts. J Bone Joint Surg Am. 2020;102(6):468-476. doi: 10.2106/JBJS.19.00432
42. Turkiewicz A, Kiadaliri AA, Englund M. Cause-specific mortality in osteoarthritis of peripheral joints. Osteoarthritis Cartilage. 2019;27:848-854. doi: 10.1016/j.joca.2019.02.793
43. Grace TR, Eralp I, Khan IA, Goh GS, Siqueira MB, Austin MS. Are patients with end-stage arthritis willing to delay arthroplasty for payer-mandated physical therapy? J Arthroplasty. 2022;37(6S):S27-S31. doi: 10.1016/j.arth.2021.11.034
44. Wang AY, Wong MS, Humbyrd CJ. Eligibility criteria for lower extremity joint replacement may worsen racial and socioeconomic disparities. Clin Orthop Relat Res. 2018;476:2301-2308. doi: 10.1097/CORR.0000000000000511
45. Dlott CC, Metcalfe T, Jain S, Bahel A, Donnelley CA, Wiznia DH. Preoperative risk management programs at the top 50 orthopaedic institutions frequently enforce strict cutoffs for BMI and hemoglobin A1c which may limit access to total joint arthroplasty and provide limited resources for smoking cessation and dental care. Clin Orthop Relat Res. 2023;481(1):39-47. doi: 10.1097/CORR.0000000000002315
46. Cleveland Clinic OME Arthroplasty Group; Arnold N, Anis H, Barsoum WK, Bloomfield MR, Brooks PJ, et al. Preoperative cutoff values for body mass index deny patients clinically significant improvements in patient-reported outcomes after total hip arthroplasty. Bone Joint J. 2020;102-B(6):683-692. doi: 10.1302/0301-620X.102B6.BJJ-2019-1644.R1
47. Carender CN, DeMik DE, Elkins JM, Brown TS, Bedard NA. Are body mass index cutoff screating racial, ethnic, and gender disparities in eligibility for primary total hip and knee arthroplasty? J Arthroplasty. 2022;37:1009-1016. doi: 10.1016/j.arth.2022.02.013
48. DeMik DE, Kohler JG, Carender CN, Glass NA, Brown TS, Bedard NA. What is the impact of body mass index cutoffs on total hip arthroplasty complications? J Arthroplasty. 2022;37(7):1320-1325. e1. doi: 10.1016/j.arth.2022.03.004
49. Roth A, Anis HK, Emara AK, Klika AK, Barsoum WK, Bloomfield MR, et al.; Cleveland Clinic OME Arthroplasty Group. The potential effects of imposing a body mass index threshold on patient-reported outcomes after total knee arthroplasty. J Arthroplasty. 2021;36(7S):S198-S208. doi: 10.1016/j.arth.2020.08.060
Review
For citations:
Amirjanova V.N., Nasonov E.L., Lila A.M. Review of the recommendations of the American College of Rheumatology and the American Association of Hip and Knee Surgeons on hip or knee arthroplasty for patient with osteoarthritis. Rheumatology Science and Practice. 2026;64(2):126-132. (In Russ.) https://doi.org/10.47360/1995-4484-2026-126-132
Views:
234
JATS XML
Email this article 